Carlyle opts for $360m trade sale over IPO for Empi

The Carlyle Group, the US private equity firm, has scrapped plans to float Empi, the US medical equipment provider, in favour of a $360m (€294m) trade sale to Encore Medical.

Encore Medical, which makes artificial knees and hips, has agreed to pay $325m in cash and 8 million worth of shares for Empi. The deal is expected to close by October.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump